SUMMARY
Objective. To assess the mortality rate from chronic kidney disease associated with kidney pathologies in the population of Azerbaijan depending on age, gender, education level, and permanent place of residence. Material and methods. All death cases in Azerbaijan in 2023 (398 cases) caused by chronic kidney disease associated with kidney pathologies were analyzed. The frequency of death cases was determined by gender, education level, age, and place of residence. Results. In Azerbaijan, there were 3.9±0.19 deaths per 100,000 population. The risk of death varied depending on gender, age, education level, and place of residence. Conclusions. The gender difference in mortality rates from chronic kidney disease associated with kidney pathologies was not significant (4.3±0.26⁰⁄₀₀₀₀ among men and 3.6±0.26⁰⁄₀₀₀₀ among women). Mortality rates were significantly higher among people with secondary and primary education (6.9±0.37⁰⁄₀₀₀₀). With age, the frequency of deaths from chronic kidney disease associated with kidney pathologies increased dynamically (from 0.1 to 32.8⁰⁄₀₀₀₀). There was a marked inequality in mortality risk across regions, cities, and districts under republican subordination.
Keywords: chronic kidney disease, kidney pathologies, risk factor, mortality, regional characteristic

---

REFERENCES

1. Гланц С. Медико-биологическая статистика. Москва. Изд. Практика. 1999. 459 с.
2. Румянцева Е.И. Хроническая болезнь почек как глобальная проблем для общественного здоровья: динамика заболеваемости и смертности // Проблемы стандартизации в здравоохранении. 2021; 1-2: 41-49. doi: 10.26347/1607-2502202101
3. Шамхалова М.Ш., Викулова О.К., Железнякова А.В., Исаков М.А. и др. Эпидемиология хронической болезни почек у пациентов с диабетом в Российской Федерации по данным Федерального регистра сахарного диабета (2010–2022 гг.) // Сахарный диабет, 2023; Т. 26, №5: С. 404-417. doi: 10.14341/DM13090
4. Helve J, Haapio M, Groop PH, Finne P. Primary kidney disease modifies the effect of comorbidities on kidney replacement therapy patients' survival // PLoS One. 2021 Aug 20;16(8):e0256522. doi: 10.1371/journal.pone.0256522
5. Maki K.C., Wilcox M.L., Dicklin M.R., Kakkar R., et al. Left ventricular mass regression, all-cause and cardiovascular mortality in chronic kidney disease: a meta-analysis // BMC Nephrol. 2022 Jan 16;23(1):34. doi: 10.1186/s12882-022-02666-1
6. Martins P., Marques E.A., Leal D.V., Ferreira A., et al. Association between physical activity and mortality in end-stage kidney disease: a systematic review of observational studies // BMC Nephrol. 2021 Jun 18;22(1):227. doi: 10.1186/s12882-021-02407-w
7. Mathers C.D., Lo1Аncar D. Projections of global mortality and burden of disease from 2002 to 2030 // PLoS Med. 2006 Nov;3(11):e442. doi: 10.1371/journal.pmed.0030442
8. Mokdad A.H., Dwyer-Lindgren L., Bertozzi-Villa A., Stubbs R.W., et al. Trends and patterns of disparities in diabetes and chronic kidney disease mortality among US counties, 1980-2014 // Popul Health Metr. 2022 Feb 22;20(1):9. doi: 10.1186/s12963-022-00285-4
9. Okamura K., Tanaka S., Kitamura H., Hiyamuta H., et al; Fukuoka Kidney Disease Registry (FKR) Study Collaboration Group. Relationships of weight change from 20 years of age with the risks of all-cause and cardiovascular mortality in patients with chronic kidney disease // J Atheroscler Thromb. 2024 Jul 1;31(7):1072-1086. doi: 10.5551/jat.64571
10. Swartling O., Rydell H., Stendahl M., Segelmark M., et al. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden // Am J Kidney Dis. 2021 Aug;78(2):190-199.e1. doi: 10.1053/j.ajkd.2020.11.026
11. Wang B., Luo Q., Zhang W., Yu S., et al. The involvement of chronic kidney disease and acute kidney injury in disease severity and mortality in patients with COVID-19: A Meta-Analysis // Kidney Blood Press Res. 2021;46(1):17-30. doi: 10.1159/000512211
12. Zhou C., Gu Y., Mei C., Dai B., et al. Dialysis modality and mortality in polycystic kidney disease // Hemodial Int. 2018 Oct;22(4):515-523. doi: 10.1111/hdi.12673